David R Williamson
Overview
Explore the profile of David R Williamson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hansen B, Farkas J, Piarulli S, Vicario S, Kvaestad B, Williamson D, et al.
Toxicol Rep
. 2021 Oct;
8:1754-1761.
PMID: 34703771
3,4-dichloroaniline (3,4-DCA) is one of the most widely produced anilines world-wide, used in plastic packaging, fabrics, pharmaceuticals, pesticides, dyes and paints as well as being a degradation product of several...
12.
Burry L, Cheng W, Williamson D, Adhikari N, Egerod I, Kanji S, et al.
Intensive Care Med
. 2021 Aug;
47(9):943-960.
PMID: 34379152
Purpose: To compare the effects of prevention interventions on delirium occurrence in critically ill adults. Methods: MEDLINE, Embase, PsychINFO, CINAHL, Web of Science, Cochrane Library, Prospero, and WHO international clinical...
13.
Duceppe M, Kanji S, Do A, Ruo N, Cavayas Y, Albert M, et al.
Drugs
. 2021 Jul;
81(11):1307-1329.
PMID: 34224115
Purpose: Adequate dosing of antimicrobials is critical to properly treat infections and limit development of resistance and adverse effects. Limited guidance exists for antimicrobial dosing adjustments in patients requiring extracorporporeal...
14.
Nicol M, Williamson D, Place D, Kirimanjeswara G
Microorganisms
. 2021 May;
9(5).
PMID: 33946283
( is a Gram-negative, facultative intracellular coccobacillus that is the etiological agent of tularemia. Interestingly, the disease tularemia has variable clinical presentations that are dependent upon the route of infection...
15.
Williamson D, Kanji S, Burry L
Can J Hosp Pharm
. 2021 Apr;
74(2):130-134.
PMID: 33896952
No abstract available.
16.
Bilodeau V, Saavedra-Mitjans M, Frenette A, Burry L, Albert M, Bernard F, et al.
J Clin Pharm Ther
. 2021 Feb;
46(4):1020-1026.
PMID: 33606290
Background: Behavioural disturbances such as agitation are common following traumatic brain injury and can interfere with treatments, cause self-harm and delay rehabilitation. As there is a lack of evidence on...
17.
Williamson D, Cherifa S, Frenette A, Saavedra Mitjans M, Charbonney E, Cataford G, et al.
Pilot Feasibility Stud
. 2020 Dec;
6(1):193.
PMID: 33308318
Background: Agitated behaviors are problematic in intensive care unit (ICU) patients recovering from traumatic brain injury (TBI) as they create substantial risks and challenges for healthcare providers. To date, there...
18.
Sneyers B, Duceppe M, Frenette A, Burry L, Rico P, Lavoie A, et al.
Drugs
. 2020 Jun;
80(12):1211-1233.
PMID: 32592134
Background: Critically ill patients are at high risk of iatrogenic withdrawal syndrome (IWS), due to exposure to high doses or prolonged periods of opioids and benzodiazepines. Purpose: To examine pharmacological...
19.
Burry L, Hutton B, Williamson D, Mehta S, Adhikari N, Cheng W, et al.
Cochrane Database Syst Rev
. 2019 Sep;
9:CD011749.
PMID: 31479532
Background: Although delirium is typically an acute reversible cognitive impairment, its presence is associated with devastating impact on both short-term and long-term outcomes for critically ill patients. Advances in our...
20.
Dupuis S, Brindamour D, Karzon S, Frenette A, Charbonney E, Perreault M, et al.
Can J Anaesth
. 2019 Jan;
66(3):318-327.
PMID: 30674004
Background: Delirium, agitation, and anxiety may hinder weaning from mechanical ventilation and lead to increased morbidity and healthcare costs. The most appropriate clinical approach to weaning in these contexts remains...